Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a phase I clinical trial
MA Exley, P Friedlander, N Alatrakchi, L Vriend… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Invariant NKT cells (iNKT) are innate-like CD1d-restricted T cells with
immunoregulatory activity in diseases including cancer. iNKT from advanced cancer patients …
immunoregulatory activity in diseases including cancer. iNKT from advanced cancer patients …
Targeted cd1d molecules
B Robert, A Donda, V Cesson, JP Mach… - US Patent …, 2017 - Google Patents
US9809654B2 - Targeted CD1d molecules - Google Patents US9809654B2 - Targeted CD1d
molecules - Google Patents Targeted CD1d molecules Download PDF Info Publication …
molecules - Google Patents Targeted CD1d molecules Download PDF Info Publication …
Modulation of NKT cell activity with antigen-loaded CD1d molecules
A Donda, JP Mach, K Stirnemann - US Patent 9,603,922, 2017 - Google Patents
The invention is directed to methods of modulating an immune response in an animal,
comprising administering a composition comprising one or more soluble CD1d com plexes …
comprising administering a composition comprising one or more soluble CD1d com plexes …
[PDF][PDF] The role of Natural Killer cells and Natural Killer T cells in HCV infection
T Senff - 2017 - core.ac.uk
Initially, Hepatitis C was described as a transfusion-associated hepatitis which was neither
hepatitis A nor hepatitis B, thus was termed non-A non-B hepatitis (NANBH)(Feinstone et al …
hepatitis A nor hepatitis B, thus was termed non-A non-B hepatitis (NANBH)(Feinstone et al …
Molekulárně biologické mechanismy progrese kolorektálního karcinomu ve vztahu k individualizované onkochirurgické léčbě
O Vyčítal - 2017 - dspace.cuni.cz
Molekulárně biologické mechanismy progrese kolorektálního karcinomu ve vztahu k
individualizované onkochirurgické léčbě Úvod: V rámci cytotoxické imunitní reakce proti …
individualizované onkochirurgické léčbě Úvod: V rámci cytotoxické imunitní reakce proti …